Selank Dosage: Doses Studied, Units and Chart
What doses of Selank have been used in published research, how they convert to syringe units, and what is still unknown.
- Doses studied
- 5 studies
- with a stated dose, listed below
- Frequency
- Varies by study
- as used in studies
- Half-life
- Not found
- No published half-life found (PubMed search, 11 Oct 2026)
- Vial sizes sold
- 5 mg, 10 mg
Doses used in published studies
Each dose below is quoted from a study abstract, strongest design first. Animal doses are labelled and do not translate directly to people. None of them is a recommendation.
| Dose | Frequency and route | Study type | Source |
|---|---|---|---|
| 0.3 mg/kg a day | daily · intraperitoneal · 7 days | Animal · rat (not a human result) | Bulletin of experimental biology and medicine 2019, PMID 31625062 |
| 300 μg/kg/day | daily · intranasal and intraperitoneal · 5 days | Animal · mouse (not a human result) | Eksperimental'naia i klinicheskaia farmakologiia 2016, PMID 29787664 |
| 300 microg/kg | single injection after the 10th trial | Animal · rat (not a human result) | Eksperimental'naia i klinicheskaia farmakologiia 2010, PMID 20919548 |
| 300 microg/kg | repeated, 15 min before training sessions · four days | Animal · rat (not a human result) | Neuroscience and behavioral physiology 2003, PMID 14552529 |
| 100 micrograms/kg | Not stated in the abstract | Animal · mouse (not a human result) | Bulletin of experimental biology and medicine 2002, PMID 12432865 |
Dose to syringe units
For a 10 mg vial mixed with 2 mL of bacteriostatic water (5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.
- 100 mcg
- 2 u
- 250 mcg
- 5 u
- 300 mcg
- 6 u
- 500 mcg
- 10 u
- 750 mcg
- 15 u
- 1000 mcg
- 20 u
Before anyone considers it
- Selank is not FDA approved for any use.
- Products sold as research chemicals are not checked by the FDA for identity, purity or dose.
- Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
- People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.
Human anxiety studies do not state an amount in their abstracts
In patients with generalized anxiety disorder and neurasthenia, selank was compared with medazepam, and the abstract does not give a dose or schedule.[12]
That study rated patients on the Hamilton, Zung and CGI scales, measured blood-serum enkephalin activity, and reported similar anxiolytic effects for selank and medazepam.[12]
A comparison with phenazepam in 60 patients likewise reports no amount, only that the anxiolytic effect lasted for a week after last receiving the peptide.[13]
Animal amounts and routes
In rats, selank at 300 microg/kg was given repeatedly 15 min before the start of training sessions.[6]
In a mouse study, selank at 300 μg/kg/day for 5 days was given by intraperitoneal and intranasal routes and the effects of the two routes were compared.[4]
In rats, 0.3 mg/kg a day for 7 days intraperitoneally was used in a memory study.[3]
No FDA-approved selank product was found, so none of these figures has a labelled counterpart.[14]
Common questions
How many units is 300 mcg of Selank?
It depends on the water added. A 10 mg vial with 2 mL of water gives 5 mg/mL, so 300 mcg is 6 units on a U-100 syringe. Use the calculator for other mixes.
Is Selank FDA approved?
No. Selank is not FDA approved for any use.
What is the selank dosage chart?
The human abstracts give no amounts, and the animal figures are per-kilogram values in rodents.[14]
What is the selank starting dose?
No starting dose is stated for people. The mouse study used 300 μg/kg/day for 5 days by two routes.[4]
Is there a selank cycle or how long is it taken?
The cited rat work dosed repeatedly before training sessions, which is animal evidence and not a human cycle.[6]
Was selank given by injection or nasal spray in studies?
A mouse study compared intraperitoneal injection with intranasal administration; anxiety-related effects appeared by both routes but only in the BALB/c strain. This is animal data, not a human regimen.[4]
More on Selank
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.Bulletin of experimental biology and medicine · 2019PMID 31625062Accessed 2 Oct 2026
- 4[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].Eksperimental'naia i klinicheskaia farmakologiia · 2016PMID 29787664Accessed 2 Oct 2026
- 5[Experimental optimization of learning and memory processes by selank].Eksperimental'naia i klinicheskaia farmakologiia · 2010PMID 20919548Accessed 2 Oct 2026
- 6The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.Neuroscience and behavioral physiology · 2003PMID 14552529Accessed 2 Oct 2026
- 7Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions.Bulletin of experimental biology and medicine · 2002PMID 12432865Accessed 2 Oct 2026
- 8PubMed search: selank[tiab] (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: selank[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: (selank[tiab] OR semax[tiab]) AND (randomized[tiab] OR patients[tiab] OR clinical[tiab]) (48 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: selank[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 12[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008PMID 18454096Accessed 2 Oct 2026
- 13[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
- 14Drugs@FDA (openFDA) search: active ingredient "selank"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
Found an error? Report a correction.